tiprankstipranks
Innovation Pharmaceuticals Inc (IPIX)
OTHER OTC:IPIX
US Market

Innovation Pharmaceuticals (IPIX) Stock Price & Analysis

130 Followers

IPIX Stock Chart & Stats

Day’s Range$0.01 - $0.02
52-Week Range― - ―
Previous Close$0.02
Volume1.03M
Average Volume (3M)N/A
Market Cap
$7.81M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
May 10, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

5.05%0.00%0.02%94.93%
5.05%
Insiders
0.02% Other Institutional Investors
94.93% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

IPIX FAQ

What was Innovation Pharmaceuticals Inc’s price range in the past 12 months?
Currently, no data Available
What is Innovation Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Innovation Pharmaceuticals Inc’s upcoming earnings report date?
Innovation Pharmaceuticals Inc’s upcoming earnings report date is May 10, 2018 which is 2172 days ago.
    How were Innovation Pharmaceuticals Inc’s earnings last quarter?
    Currently, no data Available
    Is Innovation Pharmaceuticals Inc overvalued?
    According to Wall Street analysts Innovation Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Innovation Pharmaceuticals Inc pay dividends?
      Innovation Pharmaceuticals Inc does not currently pay dividends.
      What is Innovation Pharmaceuticals Inc’s EPS estimate?
      Innovation Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Innovation Pharmaceuticals Inc have?
      Currently, no data Available
      What happened to Innovation Pharmaceuticals Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Innovation Pharmaceuticals Inc?
      Currently, no hedge funds are holding shares in IPIX
      ---

      Innovation Pharmaceuticals Stock Smart Score

      Company Description

      Innovation Pharmaceuticals Inc

      Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company. It focuses on the discover of small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism, and inflammatory disease. The company's lead cancer compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. Innovation Pharmaceuticals was founded by Krishna Kumar Menon and Leo Ehrlich in June 20, 2007 and is headquartered in Beverly, MA.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Aethlon Medical
      Novavax
      Ovid Therapeutics
      Medicinova
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis